List of insiders holdings for LogicBio Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC OrbiMed Advisors Israel II Ltd OrbiMed Israel GP II L.P. OrbiMed Genesis GP LLC Director 10% Owner |
2020-10-06 17:16:47 | 4,126,972 0 |
4,126,972 | Form 13D |
| 2 | Ioannidou Sofia Director |
2018-10-25 18:25:33 | 0 1,787,413 |
1,787,413 | Form 4 |
| 3 | Chimovits Erez Director 10% Owner |
2020-10-05 17:32:48 | 0 296,296 |
296,296 | Form 4 |
| 4 | Wilton Thomas Chief Business Officer |
2019-08-29 16:15:42 | 214,108 0 |
214,108 | Form 4 |
| 5 | Jones Cecilia Chief Financial Officer |
2022-03-03 18:05:02 | 112,000 0 |
112,000 | Form 4 |
| 6 | Paul Andrea General Counsel and Secretary |
2022-03-03 18:09:24 | 80,000 0 |
80,000 | Form 4 |
| 7 | Poole Sandra Chief Operating Officer |
2018-10-24 17:03:16 | 77,500 0 |
77,500 | Form 4/A |
| 8 | Huttner Kenneth SVP, Head of Clinical Dev. |
2020-02-13 20:00:14 | 50,000 0 |
50,000 | Form 4 |
| 9 | Falb Dean Chief Scientific Officer |
2018-10-24 17:02:31 | 30,000 0 |
30,000 | Form 4/A |
| 10 | Quick Jonathan Senior Director-Finance |
2021-01-08 17:10:03 | 29,766 0 |
29,766 | Form 3 |
| 11 | Chiang Kyle Chief Operating Officer |
2021-04-19 21:00:18 | 23,387 0 |
23,387 | Form 4 |
| 12 | Yoon Seokho Bryan Chief Admin Officer & GC |
2020-04-17 20:00:14 | 17,445 0 |
17,445 | Form 4 |
| 13 | Jaffe Matthias Chief Financial Officer |
2020-04-17 20:00:19 | 17,218 0 |
17,218 | Form 4 |
| 14 | Kariv Tomer Director |
2019-12-20 20:00:11 | 10,869 0 |
10,869 | Form 4 |
| 15 | O'Connell Daniel P Director |
2020-12-14 20:35:47 | 2,513 0 |
2,513 | Form 4 |
| 16 | Kahn Susan Director |
2022-11-17 21:02:18 | 0 0 |
0 | Form 4 |
| 17 | Kay Mark A Director |
2022-11-17 21:14:47 | 0 0 |
0 | Form 4 |
| 18 | Enyedy Mark J Director |
2022-11-17 21:13:44 | 0 0 |
0 | Form 4 |
| 19 | Nacht Mariana Chief Scientific Officer |
2022-11-17 21:12:12 | 0 0 |
0 | Form 4 |
| 20 | WYZGA MICHAEL S Director |
2022-11-17 21:11:15 | 0 0 |
0 | Form 4 |
| 21 | Chereau Frederic President, CEO |
2022-11-17 21:10:43 | 0 0 |
0 | Form 4 |
| 22 | MOSCICKI RICHARD A Director |
2022-11-17 21:09:24 | 0 0 |
0 | Form 4 |
| 23 | Goater Jeff Director |
2022-11-17 21:09:22 | 0 0 |
0 | Form 4 |
| 24 | Karydas Daphne Director |
2022-11-17 21:07:29 | 0 0 |
0 | Form 4 |
| 25 | Chen Leon Director |
2022-11-17 21:04:58 | 0 0 |
0 | Form 4 |
| 26 | Gruskin Daniel Chief Medical Officer |
2022-11-17 21:02:53 | 0 0 |
0 | Form 4 |
| 27 | Blacher Joshua Interim CFO |
2022-09-30 17:00:10 | 0 0 |
0 | Form 3 |
| 28 | Arix Bioscience plc Arix Bioscience Holdings Ltd 10% Owner |
2023-02-10 16:40:05 | 0 0 |
0 | Form 13D |